Neuroblastoma outcomes improved with second stem cell transplant

Bookmark and Share
Published: 6 Jun 2016
Views: 1679
Dr Julie Park - Seattle Children's Hospital, Seattle, USA

Dr Park speaks with ecancertv at ASCO 2016 about the improved patient outcomes among children with high risk neuroblastoma following an additional autologous stem cell transplantation (ASCT).

Historically, less than 50% of children with high-risk neuroblastoma live five or more years after diagnosis, but Dr Park reports that, at 3 years, 61.4% of patients who received a double transplant were alive and cancer-free, compared to 48.4% of those who received a single transplant, with similar side effects between groups.

For more on this research, you can watch her press release here.